Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor11CRESTOR is a trademark, the property of AstraZeneca PLC. Research discussed in this article was supported by AstraZeneca.

Publication | Closed Access

DOI

412

Citations

References

2001

Year

Fergus McTaggart, Linda K. Buckett, Robert G. Davidson, Alex McCormick, Dennis W. Schneck, Graham Smith, Michael J. Warwick

The American Journal of Cardiology

Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceOxysterolBiochemistryMedicineNatural SciencesAstrazeneca PlcMechanism Of ActionClinical PharmacologyPharmacotherapyReactive Oxygen SpeciePharmacologyDrug DiscoveryOxidative Stress